%PDF-1.6
%
1 0 obj
<>stream
2021-02-17T17:23:41+05:30
2021-02-21T17:37:40-08:00
2021-02-21T17:37:40-08:00
LaTeX with hyperref package
Acrobat Distiller 10.1.10 (Windows); modified using iText 4.2.0 by 1T3XT
10.1002/cac2.12135
10.1002/(ISSN)2523-3548
3
VoR
10.1002/cac2.12135
application/pdf
Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study
uuid:eb1cb07b-fa08-3505-93a2-d422eb27242b
uuid:1d80b921-0427-4fbe-a4c4-de09a1a8424c
endstream
endobj
4 0 obj
<>stream
x\Y~_/`We>P,Z+ccCCOwL} E26=*H$Fwqw{5nd7_|}wSL7"/艚=ܔyMh]T5檴4hu[{QXo-7aRICQ؉Udɿ)rW''
_yU=>i3`yQZVέ!7U05|ONy(s[Wu:<%^@,,x-iz0ZMѹ!>~mOx4Y
([M*WEɝ:e<}wӵ-Y6M^ި<8@:,(<ܛ@]̃&Jm.NMMGt'7O7Іi%+] s &ϡt^%t
-ohi*/ؚ*5ZCzOh뷺źX]aT',,2Mթ%KS_y|su+chJZnB
Uii5DIKl Є)5\;j+M &XPii*:%F#QxthKsMƍe^+jTM4mŁRjȵb3ͱ ֦25m^q|%-1$SKc ӒvtVh:߶IV2Syi:H:
=k@J8й(s&ЬfM8+"U=~jxp+:QHI&iIޖ87ԔY!)lI6@-gUo1m['2jm51I8!qpī MXȝTQ!p77ؚE5ԑv
;hq|LV Mۧf=#Qf=QTe?*f{2L6o>Юezz17_PSK@Bhf6df۩Eg%-|lW g2
&nMhF`OUEla!|+1z*
nAɃ#Yf_eu4\$iwoylxK'%kaCi9q'6 5a&Te`f> PtDͲQ(
ʾEaxa64s!ABLv6R1q"fETr@F8|W q$ en#Dݮ-ƳGVfz/hZ2>|*Xm]Z<Ⱥ"D+zwXw\LuS&zz+Zg
ͱ
=IJTJ`S-Z>%>Q}تW2/v}ϿͮVc{=HBngғ'S'23rrciw1LYGJtX.EW(y{SpaIq.Il}>!C Ľ!X(@3 jSWCBR2:(!uCh>0,@tζIJloӱV!Ɩ,݃ vu.c|<͊)>YV˵-M{3>^ݹ@0J1XqCf.[Zu: b +>6y&4'&͖"c5Lf]3m&r3zvS-'d2YY))"Gt,&:oXГ |vZn<,#Et +4c*=y$*T.e{mW%o(1f?8H#kG:.EiiicwJdˋcr=r%US4lժ* z
P;3%rC:@:r{HM{ɰev^*d1' h=^_f*6B1h#Oxew